GSTM1 and tuberculosis: In summary, the current meta-analysis results demonstrate that GSTM1, rather than GSTT1, may act as a molecular link between ATDILI and SCZ and suggest that ATDILI and SCZ may be concurrent adverse effects of anti-TB drugs in subjects harboring the GSTM1 null genotype.